← Back to directory
HV
Hadean Ventures
Oslo, NorwayWebsite ↗
Hadean Ventures is a European venture capital firm established in 2014, focusing on the life sciences sector and investing in innovative healthcare solutions that address significant medical needs. The firm manages funds and supports companies across various healthcare verticals and stages of development, aiming to generate strong returns and make a meaningful impact.
Last raised
Dec 2023
2y 7mo ago
Latest fund size
$155.5M
Hadean Capital II
AUM
$248.4M
estimated
Funds raised
Capital this firm has raised, newest first
Hadean Capital II
Dec 2023
$155.5M
Hadean Capital I
Jan 2014
$92.9M
Recent investments
Companies this firm has funded, newest first
| Company | Round | Amount | Date | Source |
|---|---|---|---|---|
| TargED Biopharmaceuticals | — | — | Dec 2025 | |
| Step Pharma | Series C | $41M | Oct 2025 | |
| Arthex Biotech | Series B | $87M | Sep 2025 | |
| Gesynta Pharma | Series B | $33.3M | Aug 2025 | |
| Neuro Event Labs Oy | — | $2.2M | Feb 2025 | |
| Alex Therapeutics | — | — | Dec 2023 | |
| Complement Therapeutics | — | — | Dec 2023 | |
| Ribbon Biolabs | — | — | Dec 2023 |
Sources
Where this data came from